Cosmo Technologies Limited v. Actavis Laboratories, Inc.

Application Number	Patent Number	External Links
-	US9132093	Espacenet Google Patents

COMPLAINT filed against Actavis Laboratories FL,Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1826978.) - filed by Valeant Pharmaceuticals International, Cosmo Technologies Limited, Valeant Pharmaceuticals Luxembourg S.A.R.L..(Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(aah) (Entered: 11/13/2015)

2015-11-13

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 11/13/2015)

2015-11-13

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/9/2015. Date of Expiration of Patent: 9/7/2031.Thirty Month Stay Deadline:4/9/2018. (aah) (Entered: 11/13/2015)

2015-11-13

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,093 B2; (aah) (Entered: 11/13/2015)

2015-11-13

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cosmo Pharmaceuticals SA, Corporate Parent Cosmo Holding SARL for Cosmo Technologies Limited filed by Cosmo Technologies Limited. (aah) (Entered: 11/13/2015)

2015-11-13

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Valeant Pharmaceuticals International, Inc., Corporate Parent Valeant International Luxembourg S.a.r.l, Corporate Parent Valeant Holdings Ireland for Valeant Pharmaceuticals Luxembourg S.A.R.L. filed by Valeant Pharmaceuticals Luxembourg S.A.R.L.(aah) (Entered: 11/13/2015)

2015-11-13

1

View

Summons Issued

2015-11-13

1

No Actions

SUMMONS Returned Executed by Valeant Pharmaceuticals International, Cosmo Technologies Limited, Valeant Pharmaceuticals Luxembourg S.A.R.L.. Actavis Laboratories FL, Inc. served on 11/16/2015, answer due 12/7/2015. (Noreika, Maryellen) (Entered: 11/17/2015)

2015-11-17

1

View

Case Assigned/Reassigned

2015-11-18

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Melanie R. Rupert, David M. Conca, Jennifer T. Nguyen, Scott F. Peachman, Nicholas A. Tymoczko - filed by Cosmo Technologies Limited, Valeant Pharmaceuticals Luxembourg S.A.R.L., Valeant Pharmaceuticals International. (Noreika, Maryellen) (Main Document 8 replaced on 11/24/2015) (ntl). Modified on 11/24/2015 (ntl). (Entered: 11/24/2015)

2015-11-24

1

View

SO ORDERED

2015-11-24

1

No Actions

- CORRECTING ENTRY

2015-11-24

1

No Actions

Add Attorneys - PHV only

2015-11-30

1

No Actions

Add Attorneys - PHV only

2015-11-30

1

No Actions

ANSWER to 1 Complaint, Affirmative Defenses and, COUNTERCLAIM against Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L. by Actavis Laboratories FL, Inc..(Phillips, John) (Entered: 12/07/2015)

2015-12-07

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Actavis Laboratories FL, Inc. filed by Actavis Laboratories FL, Inc.. (Phillips, John) (Entered: 12/07/2015)

2015-12-07

1

View

Add Attorneys - PHV only

2015-12-09

1

No Actions

ANSWER to 9 Answer to Complaint,, Counterclaim, by Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L..(Noreika, Maryellen) (Entered: 01/04/2016)

2016-01-04

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than March 18, 2016. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 3/4/16. Associated Cases: 1:15-cv-00669-LPS, 1:15-cv-01046-LPS, 1:15-cv-01047-LPS, 1:15-cv-01049-LPS (ntl) (Entered: 03/04/2016)

2016-03-04

1

View

Order

2016-03-04

1

No Actions

STIPULATION of Dismissal and [Proposed] Order by Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. (Noreika, Maryellen) (Entered: 03/18/2016)

2016-03-18

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,093. (ntl) (Entered: 03/21/2016)

2016-03-21

1

View

~Util - Terminate Civil Case AND SO ORDERED

2016-03-21

1

No Actions

SO ORDERED, re 13 Stipulation of Dismissal filed by Valeant Pharmaceuticals Luxembourg S.A.R.L., Cosmo Technologies Limited, Valeant Pharmaceuticals International, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 3/21/16. (ntl)

2016-03-21

1

No Actions

Overview

Parties

Counter Defendant

Valeant Pharmaceuticals Luxembourg S.A.R.L.

Represented By

Cosmo Technologies Limited

Represented By

Counter Claimant

Actavis Laboratories FL, Inc.

Represented By

Plaintiff

Valeant Pharmaceuticals International

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 11/13/2015)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/9/2015. Date of Expiration of Patent: 9/7/2031.Thirty Month Stay Deadline:4/9/2018. (aah) (Entered: 11/13/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,093 B2; (aah) (Entered: 11/13/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cosmo Pharmaceuticals SA, Corporate Parent Cosmo Holding SARL for Cosmo Technologies Limited filed by Cosmo Technologies Limited. (aah) (Entered: 11/13/2015)

Summons Issued

SUMMONS Returned Executed by Valeant Pharmaceuticals International, Cosmo Technologies Limited, Valeant Pharmaceuticals Luxembourg S.A.R.L.. Actavis Laboratories FL, Inc. served on 11/16/2015, answer due 12/7/2015. (Noreika, Maryellen) (Entered: 11/17/2015)

Case Assigned/Reassigned

SO ORDERED

- CORRECTING ENTRY

Add Attorneys - PHV only

Add Attorneys - PHV only

ANSWER to 1 Complaint, Affirmative Defenses and, COUNTERCLAIM against Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L. by Actavis Laboratories FL, Inc..(Phillips, John) (Entered: 12/07/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Actavis Laboratories FL, Inc. filed by Actavis Laboratories FL, Inc.. (Phillips, John) (Entered: 12/07/2015)

Add Attorneys - PHV only

ANSWER to 9 Answer to Complaint,, Counterclaim, by Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L..(Noreika, Maryellen) (Entered: 01/04/2016)

Order

STIPULATION of Dismissal and [Proposed] Order by Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. (Noreika, Maryellen) (Entered: 03/18/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,093. (ntl) (Entered: 03/21/2016)

~Util - Terminate Civil Case AND SO ORDERED

SO ORDERED, re 13 Stipulation of Dismissal filed by Valeant Pharmaceuticals Luxembourg S.A.R.L., Cosmo Technologies Limited, Valeant Pharmaceuticals International, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 3/21/16. (ntl)

Cosmo Technologies Limited v. Actavis Laboratories, Inc.

Overview

Parties

Counter Defendant

Valeant Pharmaceuticals Luxembourg S.A.R.L. Follow

Represented By

Cosmo Technologies Limited Follow

Represented By

Counter Claimant

Actavis Laboratories FL, Inc. Follow

Represented By

Plaintiff

Valeant Pharmaceuticals International Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 11/13/2015)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/9/2015. Date of Expiration of Patent: 9/7/2031.Thirty Month Stay Deadline:4/9/2018. (aah) (Entered: 11/13/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,093 B2; (aah) (Entered: 11/13/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cosmo Pharmaceuticals SA, Corporate Parent Cosmo Holding SARL for Cosmo Technologies Limited filed by Cosmo Technologies Limited. (aah) (Entered: 11/13/2015)

Summons Issued

SUMMONS Returned Executed by Valeant Pharmaceuticals International, Cosmo Technologies Limited, Valeant Pharmaceuticals Luxembourg S.A.R.L.. Actavis Laboratories FL, Inc. served on 11/16/2015, answer due 12/7/2015. (Noreika, Maryellen) (Entered: 11/17/2015)

Case Assigned/Reassigned

SO ORDERED

- CORRECTING ENTRY

Add Attorneys - PHV only

Add Attorneys - PHV only

ANSWER to 1 Complaint, Affirmative Defenses and, COUNTERCLAIM against Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L. by Actavis Laboratories FL, Inc..(Phillips, John) (Entered: 12/07/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Actavis Laboratories FL, Inc. filed by Actavis Laboratories FL, Inc.. (Phillips, John) (Entered: 12/07/2015)

Add Attorneys - PHV only

ANSWER to 9 Answer to Complaint,, Counterclaim, by Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L..(Noreika, Maryellen) (Entered: 01/04/2016)

Order

STIPULATION of Dismissal and [Proposed] Order by Cosmo Technologies Limited, Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.A.R.L.. (Noreika, Maryellen) (Entered: 03/18/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,093. (ntl) (Entered: 03/21/2016)

~Util - Terminate Civil Case AND SO ORDERED

SO ORDERED, re 13 Stipulation of Dismissal filed by Valeant Pharmaceuticals Luxembourg S.A.R.L., Cosmo Technologies Limited, Valeant Pharmaceuticals International, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 3/21/16. (ntl)

Track Case Updates

Valeant Pharmaceuticals Luxembourg S.A.R.L.

Cosmo Technologies Limited

Actavis Laboratories FL, Inc.

Valeant Pharmaceuticals International